By Colin Kellaher
Pulse Biosciences has hired Jon Skinner as the bioelectric medicine company's new chief financial officer.
Pulse on Tuesday said Skinner most recently served as vice president of financial planning and analysis and investor relations at private-equity backed industrial company Copeland.
Paul LaViolette, who became president and chief executive of Pulse last month, has been serving as the Miami company's principal financial officer.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
February 04, 2025 08:21 ET (13:21 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.